Could a new drug match the standard for liver cancer treatment?
NCT ID NCT06114082
First seen Aug 20, 2026 · Last updated Aug 21, 2026 · Updated 1 time
Summary
This trial is testing whether a chemotherapy drug called idarubicin works as well as the standard drug doxorubicin when used in a procedure called transarterial chemoembolization (TACE) for liver cancer. TACE delivers chemotherapy directly to the tumor and blocks its blood supply. The study will include adults with hepatocellular carcinoma who have not had prior treatment. The goal is to see if idarubicin is not inferior to doxorubicin in shrinking or controlling tumors.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- idarubicin
- What this could lead to
- If idarubicin proves as effective as doxorubicin, it could offer an alternative chemoembolization option for liver cancer patients, potentially with different side effects or benefits.
- What could go wrong
- This is a phase 2 trial, so results are preliminary. The study may not show a significant difference, or idarubicin could have unforeseen side effects. Non-inferiority trials also have specific statistical limitations.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEPATOCELLULAR CARCINOMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Seoul National University Hospital
Seoul, 03080, South Korea
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- A card game could open the door to better End-of-Life conversations
- Can a One-Time radiation bead treatment extend life in advanced liver cancer?
- Can a single radiation dose cure large liver tumors?
- Can a prostate cancer scan also spot liver tumors?
- Could a simple scan and blood test outsmart liver cancer?
- Could a vaccine help fight Hard-to-Treat cancers?